| Year |
Citation |
Score |
| 2023 |
Martin H, Coursan A, Lallement J, Di Miceli M, Kandiah J, Raho I, Buttler J, Guilloux JP, De Deurwaerdere P, Layé S, Guiard BP, Magnan C, Cruciani-Guglielmacci C, Fioramonti X. Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia. Journal of Neuroendocrinology. e13344. PMID 37857383 DOI: 10.1111/jne.13344 |
0.669 |
|
| 2023 |
Orrico-Sanchez A, Guiard BP, Manta S, Callebert J, Launay JM, Louis F, Paccard A, Gruszczynski C, Betancur C, Vialou V, Gautron S. Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain. Translational Psychiatry. 13: 302. PMID 37775532 DOI: 10.1038/s41398-023-02596-y |
0.361 |
|
| 2023 |
Coutens B, Lejards C, Bouisset G, Verret L, Rampon C, Guiard BP. Enriched environmental exposure reduces the onset of action of the serotonin norepinephrin reuptake inhibitor venlafaxine through its effect on parvalbumin interneurons plasticity in mice. Translational Psychiatry. 13: 227. PMID 37365183 DOI: 10.1038/s41398-023-02519-x |
0.376 |
|
| 2022 |
Portal B, Vasile F, Zapata J, Lejards C, Ait Tayeb AEK, Colle R, Verstuyft C, Corruble E, Rouach N, Guiard BP. Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal. International Journal of Molecular Sciences. 23. PMID 36362016 DOI: 10.3390/ijms232113227 |
0.362 |
|
| 2022 |
Martin H, Bullich S, Martinat M, Chataigner M, Di Miceli M, Simon V, Clark S, Butler J, Schell M, Chopra S, Chaouloff F, Kleinridders A, Cota D, De Deurwaerdere P, Pénicaud L, ... ... Guiard BP, et al. Insulin modulates emotional behavior through a serotonin-dependent mechanism. Molecular Psychiatry. PMID 36207585 DOI: 10.1038/s41380-022-01812-3 |
0.804 |
|
| 2022 |
Delanogare E, Bullich S, Dos Santos Barbosa LA, de Medeiros Barros W, Braga SP, Kraus SI, Kasprowicz JN, Dos Santos GJ, Guiard BP, Moreira ELG. Metformin improves neurobehavioral impairments of streptozotocin-treated and western diet-fed mice: Beyond glucose-lowering effects. Fundamental & Clinical Pharmacology. PMID 35996325 DOI: 10.1111/fcp.12825 |
0.762 |
|
| 2022 |
Coutens B, Yrondi A, Rampon C, Guiard BP. Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine. Psychopharmacology. 239: 2735-2752. PMID 35947166 DOI: 10.1007/s00213-022-06203-8 |
0.401 |
|
| 2021 |
Martin H, Bullich S, Guiard BP, Fioramonti X. The impact of insulin on the serotonergic system and consequences on diabetes-associated mood disorders. Journal of Neuroendocrinology. e12928. PMID 33506507 DOI: 10.1111/jne.12928 |
0.796 |
|
| 2021 |
Bullich S, Delcourte S, Haddjeri N, Guiard BP. Learned Immobility Produces Enduring Impairment of the HPA Axis Reactivity in Mice without Replicating the Broad Spectrum of Depressive-Like Phenotype. International Journal of Molecular Sciences. 22. PMID 33477830 DOI: 10.3390/ijms22020937 |
0.79 |
|
| 2020 |
Coutens B, Rekik K, Harster A, Etienne P, Noirot V, Frances B, Moulédous L, Guiard BP. A Citrus based sensory functional food ingredient induces antidepressant-like effects: possible involvement of an interplay between the olfactory and the serotonergic systems. Neuroscience. PMID 33039523 DOI: 10.1016/j.neuroscience.2020.09.040 |
0.335 |
|
| 2020 |
Portal B, Delcourte S, Rovera R, Lejards C, Bullich S, Malnou CE, Haddjeri N, Déglon N, Guiard BP. Genetic and pharmacological inactivation of astroglial connexin 43 differentially influences the acute response of antidepressant and anxiolytic drugs. Acta Physiologica (Oxford, England). e13440. PMID 31925934 DOI: 10.1111/apha.13440 |
0.787 |
|
| 2020 |
MARTIN H, BULLICH S, DUCROCQ F, GRALAND M, OLIVRY C, LAYE S, GUIARD B, FIORAMONTI X. 1758-P: Type 2 Diabetes–Associated Mood Disorders: Role of Insulin Resistance in Serotonergic Neurons Diabetes. 69: 1758-P. DOI: 10.2337/Db20-1758-P |
0.452 |
|
| 2019 |
Faye C, Hen R, Guiard BP, Denny CA, Gardier AM, Mendez-David I, David DJ. Rapid Anxiolytic Effects of RS67333, a Serotonin Type 4 Receptor Agonist, and Diazepam, a Benzodiazepine, Are Mediated by Projections From the Prefrontal Cortex to the Dorsal Raphe Nucleus. Biological Psychiatry. PMID 31623825 DOI: 10.1016/j.biopsych.2019.08.009 |
0.626 |
|
| 2019 |
Orrico-Sanchez A, Chausset-Boissarie L, Alves de Sousa R, Coutens B, Rezai Amin S, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T, Gruszczynski C, Giros B, Guiard BP, Acher F, Pietrancosta N, et al. Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression. Molecular Psychiatry. PMID 31619760 DOI: 10.1038/S41380-019-0548-4 |
0.357 |
|
| 2019 |
Zemdegs J, Martin H, Pintana H, Bullich S, Manta S, Marqués MA, Moro C, Layé S, Ducrocq F, Chattipakorn N, Chattipakorn SC, Rampon C, Pénicaud L, Fioramonti X, Guiard BP. Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31160539 DOI: 10.1523/Jneurosci.2904-18.2019 |
0.827 |
|
| 2018 |
Zemdegs J, Rainer Q, Grossmann CP, Rousseau-Ralliard D, Grynberg A, Ribeiro E, Guiard BP. Anxiolytic- and Antidepressant-Like Effects of Fish Oil-Enriched Diet in Brain-Derived Neurotrophic Factor Deficient Mice. Frontiers in Neuroscience. 12: 974. PMID 30622454 DOI: 10.3389/fnins.2018.00974 |
0.342 |
|
| 2018 |
Belmer A, Quentin E, Diaz SL, Guiard BP, Fernandez SP, Doly S, Banas SM, Pitychoutis PM, Moutkine I, Muzerelle A, Tchenio A, Roumier A, Mameli M, Maroteaux L. Positive regulation of raphe serotonin neurons by serotonin 2B receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29453444 DOI: 10.1038/s41386-018-0013-0 |
0.357 |
|
| 2018 |
Faye C, Hen R, Guiard B, Denny CA, Gardier A, Mendez-David I, David D. T37. Rapid Anxiolytic Effects of a Serotonin Type 4 Receptor Agonist Involve Prefrontal Cortex-Brainstem Neural Circuit Recruitment Biological Psychiatry. 83: S143. DOI: 10.1016/J.Biopsych.2018.02.373 |
0.582 |
|
| 2017 |
Moutkine I, Quentin E, Guiard BP, Maroteaux L, Doly S. Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers. The Journal of Biological Chemistry. PMID 28258217 DOI: 10.1074/jbc.M117.779041 |
0.311 |
|
| 2017 |
Garcia-Garcia AL, Meng Q, Canetta S, Gardier AM, Guiard BP, Kellendonk C, Dranovsky A, Leonardo ED. Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors. Cell Reports. 18: 1144-1156. PMID 28147271 DOI: 10.1016/J.Celrep.2017.01.021 |
0.642 |
|
| 2017 |
Pham TH, Mendez-David I, Defaix C, Guiard BP, Tritschler L, David DJ, Gardier AM. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice. Neuropharmacology. 112: 198-209. PMID 27211253 DOI: 10.1016/j.neuropharm.2016.05.010 |
0.664 |
|
| 2016 |
Besson M, Guiducci S, Granon S, Guilloux JP, Guiard B, Repérant C, Faure P, Pons S, Cannazza G, Zoli M, Gardier AM, Maskos U. Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments. Psychopharmacology. 233: 3297-314. PMID 27385416 DOI: 10.1007/S00213-016-4362-2 |
0.7 |
|
| 2016 |
Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach. Neuropharmacology. 105: 142-53. PMID 26764241 DOI: 10.1016/J.Neuropharm.2015.12.022 |
0.768 |
|
| 2015 |
Quesseveur G, Portal B, Basile JA, Ezan P, Mathou A, Halley H, Leloup C, Fioramonti X, Déglon N, Giaume C, Rampon C, Guiard BP. Attenuated Levels of Hippocampal Connexin 43 and its Phosphorylation Correlate with Antidepressant- and Anxiolytic-Like Activities in Mice. Frontiers in Cellular Neuroscience. 9: 490. PMID 26733815 DOI: 10.3389/Fncel.2015.00490 |
0.798 |
|
| 2015 |
Zemdegs J, Quesseveur G, Jarriault D, Pénicaud L, Fioramonti X, Guiard BP. High fat diet-induced metabolic disorders impairs serotonergic function and anxiety-like behaviours in mice. British Journal of Pharmacology. PMID 26472268 DOI: 10.1111/Bph.13343 |
0.78 |
|
| 2015 |
Guiard BP, Di Giovanni G. Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link? Frontiers in Pharmacology. 6: 46. PMID 25852551 DOI: 10.3389/fphar.2015.00046 |
0.382 |
|
| 2015 |
Couroussé T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet AM, Gardier AM, Schinkel AH, Giros B, Gautron S. Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling. Molecular Psychiatry. 20: 889-900. PMID 25092247 DOI: 10.1038/Mp.2014.86 |
0.596 |
|
| 2015 |
Hache G, Guiard BP, Nguyen TH, Quesseveur G, Gardier AM, Peters D, Munro G, Coudoré F. Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain. European Journal of Pain (London, England). 19: 322-33. PMID 25045036 DOI: 10.1002/Ejp.550 |
0.775 |
|
| 2014 |
Le Dantec Y, Hache G, Guilloux JP, Guiard BP, David DJ, Adrien J, Escourrou P. NREM sleep hypersomnia and reduced sleep/wake continuity in a neuroendocrine mouse model of anxiety/depression based on chronic corticosterone administration. Neuroscience. 274: 357-68. PMID 24909899 DOI: 10.1016/J.Neuroscience.2014.05.050 |
0.752 |
|
| 2014 |
Petit AC, Quesseveur G, Gressier F, Colle R, David DJ, Gardier AM, Ferreri F, Lépine JP, Falissard B, Verstuyft C, Guiard BP, Corruble E. Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 76-82. PMID 24801750 DOI: 10.1016/J.Pnpbp.2014.04.013 |
0.808 |
|
| 2014 |
Zemdegs J, Ly K, Gardier A, Pénicaud L, Guiard B, Fioramonti X. PO22 Comportements de type anxieux et dépréssif induit par un régime alimentaire hyperlipidique chez la souris adulte Diabetes & Metabolism. 40: A26. DOI: 10.1016/S1262-3636(14)72280-3 |
0.521 |
|
| 2013 |
Quesseveur G, Gardier AM, Guiard BP. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs. Current Drug Targets. 14: 1277-94. PMID 24020973 DOI: 10.2174/13894501113149990209 |
0.817 |
|
| 2013 |
Guilloux JP, Mendez-David I, Pehrson A, Guiard BP, Repérant C, Orvoën S, Gardier AM, Hen R, Ebert B, Miller S, Sanchez C, David DJ. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology. 73: 147-59. PMID 23721744 DOI: 10.1016/J.Neuropharm.2013.05.014 |
0.78 |
|
| 2013 |
Quesseveur G, David DJ, Gaillard MC, Pla P, Wu MV, Nguyen HT, Nicolas V, Auregan G, David I, Dranovsky A, Hantraye P, Hen R, Gardier AM, Déglon N, Guiard BP. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Translational Psychiatry. 3: e253. PMID 23632457 DOI: 10.1038/Tp.2013.30 |
0.813 |
|
| 2013 |
Quesseveur G, Repérant C, David DJ, Gardier AM, Sanchez C, Guiard BP. 5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system. Experimental Brain Research. 226: 285-95. PMID 23411676 DOI: 10.1007/S00221-013-3434-3 |
0.841 |
|
| 2013 |
Nguyen HT, Guiard BP, Bacq A, David DJ, David I, Quesseveur G, Gautron S, Sanchez C, Gardier AM. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice. British Journal of Pharmacology. 168: 103-16. PMID 22233336 DOI: 10.1111/J.1476-5381.2012.01850.X |
0.816 |
|
| 2013 |
Guiard B, Quesseuveur G, Gardier A, Penicaud L, Fioramonti X. P2065 Impact du diabète de type 2 sur l’état de type « dépressif » chez la souris Diabetes & Metabolism. 39: A83-A84. DOI: 10.1016/S1262-3636(13)71975-X |
0.546 |
|
| 2013 |
Quesseveur G, Petit A, Gressier F, Colle R, David D, Gardier A, Verstuyft C, Sanchez C, Corruble E, Guiard B. S.12.07 Role of 5-HT1A/5-HT2A receptors interaction in the severity of depression and antidepressant response European Neuropsychopharmacology. 23: S131. DOI: 10.1016/S0924-977X(13)70173-1 |
0.779 |
|
| 2013 |
Quesseveur G, Petit A, Gressier F, Colle R, David D, Gardier A, Verstuyft C, Corruble E, Guiard B. P.1.019 Role of the 5-HT2A receptor in the mechanism of action of antidepressant drugs: a translational human–mouse study European Neuropsychopharmacology. 23: S18-S19. DOI: 10.1016/S0924-977X(13)70021-X |
0.758 |
|
| 2013 |
Petit A, Quesseveur G, Gressier F, Verstuyft C, Guiard B, Corruble E. Association entre polymorphismes du gène du récepteur 2A à la sérotonine et trouble dépressif majeur unipolaire, une étude translationnelle European Psychiatry. 28: 31-32. DOI: 10.1016/J.Eurpsy.2013.09.077 |
0.705 |
|
| 2012 |
Quesseveur G, Nguyen HT, Gardier AM, Guiard BP. 5-HT2 ligands in the treatment of anxiety and depression. Expert Opinion On Investigational Drugs. 21: 1701-25. PMID 22917059 DOI: 10.1517/13543784.2012.719872 |
0.828 |
|
| 2012 |
Hache G, Guiard BP, Le Dantec Y, Orvoën S, David DJ, Gardier AM, Coudoré F. Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression. Neuroreport. 23: 525-9. PMID 22555563 DOI: 10.1097/Wnr.0B013E328353D70A |
0.779 |
|
| 2012 |
Rainer Q, Nguyen HT, Quesseveur G, Gardier AM, David DJ, Guiard BP. Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration. Molecular Pharmacology. 81: 106-12. PMID 22031471 DOI: 10.1124/Mol.111.075796 |
0.837 |
|
| 2012 |
Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Molecular Psychiatry. 17: 926-39. PMID 21769100 DOI: 10.1038/Mp.2011.87 |
0.699 |
|
| 2012 |
Guiard BP, Mansari ME, Murphy DL, Blier P. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 349-61. PMID 21439106 DOI: 10.1017/S1461145711000484 |
0.44 |
|
| 2011 |
Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, David DJ, Guiard BP, Beck SG, Hen R, Leonardo ED. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 6008-18. PMID 21508226 DOI: 10.1523/JNEUROSCI.5836-10.2011 |
0.643 |
|
| 2011 |
Guilloux JP, David DJ, Xia L, Nguyen HT, Rainer Q, Guiard BP, Repérant C, Deltheil T, Toth M, Hen R, Gardier AM. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology. 61: 478-88. PMID 21333660 DOI: 10.1016/J.Neuropharm.2011.02.009 |
0.776 |
|
| 2011 |
Guiard BP, Chenu F, El Mansari M, Blier P. Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 211-23. PMID 20149268 DOI: 10.1017/S1461145710000076 |
0.358 |
|
| 2011 |
Hache G, Coudore F, Gardier AM, Guiard BP. Monoaminergic antidepressants in the relief of pain: Potential therapeutic utility of triple reuptake inhibitors (TRIs) Pharmaceuticals. 4: 285-342. DOI: 10.3390/Ph4020285 |
0.793 |
|
| 2010 |
El Mansari M, Guiard BP, Chernoloz O, Ghanbari R, Katz N, Blier P. Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. Cns Neuroscience & Therapeutics. 16: e1-17. PMID 20406250 DOI: 10.1111/J.1755-5949.2010.00146.X |
0.332 |
|
| 2010 |
Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, Gardier AM, Dranovsky A, David DJ, Beck SG, Hen R, Leonardo ED. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron. 65: 40-52. PMID 20152112 DOI: 10.1016/J.Neuron.2009.12.003 |
0.628 |
|
| 2010 |
Popa D, Cerdan J, Repérant C, Guiard BP, Guilloux JP, David DJ, Gardier AM. A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. European Journal of Pharmacology. 628: 83-90. PMID 19944680 DOI: 10.1016/j.ejphar.2009.11.037 |
0.778 |
|
| 2009 |
Guiard BP, El Mansari M, Blier P. Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Current Drug Targets. 10: 1069-84. PMID 19702555 DOI: 10.2174/138945009789735156 |
0.409 |
|
| 2009 |
David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron. 62: 479-93. PMID 19477151 DOI: 10.1016/J.Neuron.2009.04.017 |
0.75 |
|
| 2009 |
Gardier AM, Guiard BP, Guilloux JP, Repérant C, Coudoré F, David DJ. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review. Fundamental & Clinical Pharmacology. 23: 23-42. PMID 19267769 DOI: 10.1111/j.1472-8206.2008.00640.x |
0.793 |
|
| 2009 |
Guiard B, Chenu F, El Mansari M, Blier P. P.1.c.059 Electrophysiological properties of the triple reuptake inhibitor SEP 225289 on monoaminergic neurons European Neuropsychopharmacology. 19: S285. DOI: 10.1016/S0924-977X(09)70419-5 |
0.442 |
|
| 2009 |
Gardier A, Deltheil T, Tanaka K, Reperant C, Hen R, David D, Guiard B. S.20.04 Consequences of altered BDNF protein levels on hippocampal serotonin neurotransmission and behaviour European Neuropsychopharmacology. 19: S205-S206. DOI: 10.1016/S0924-977X(09)70272-X |
0.551 |
|
| 2008 |
Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 55: 1006-14. PMID 18761360 DOI: 10.1016/j.neuropharm.2008.08.001 |
0.786 |
|
| 2008 |
Deltheil T, Guiard BP, Guilloux JP, Nicolas L, Deloménie C, Repérant C, Le Maitre E, Leroux-Nicollet I, Benmansour S, Coudoré F, David DJ, Gardier AM. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus. Pharmacology, Biochemistry, and Behavior. 90: 174-83. PMID 17980409 DOI: 10.1016/j.pbb.2007.09.018 |
0.777 |
|
| 2008 |
Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. The International Journal of Neuropsychopharmacology. 11: 79-92. PMID 17559709 DOI: 10.1017/S1461145707007857 |
0.661 |
|
| 2007 |
Guiard BP, Guilloux JP, Reperant C, Hunt SP, Toth M, Gardier AM. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex. Molecular Pharmacology. 72: 1411-8. PMID 17890358 DOI: 10.1124/mol.107.040113 |
0.78 |
|
| 2006 |
Chenu F, Guiard BP, Bourin M, Gardier AM. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behavioural Brain Research. 172: 256-63. PMID 16806519 DOI: 10.1016/j.bbr.2006.05.011 |
0.671 |
|
| 2006 |
Guiard BP, Lanfumey L, Gardier AM. Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review. Current Drug Targets. 7: 187-201. PMID 16475960 |
0.659 |
|
| 2006 |
Guilloux JP, David DJ, Guiard BP, Chenu F, Repérant C, Toth M, Bourin M, Gardier AM. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2162-72. PMID 16452992 DOI: 10.1038/sj.npp.1301019 |
0.792 |
|
| 2006 |
Guiard B, Gardier A, Blier P. Potentiating antidepressant strategy: focus on NK1 receptor antagonists European Neuropsychopharmacology. 16: S31-S32. DOI: 10.1016/S0924-977X(06)80039-8 |
0.534 |
|
| 2005 |
Guiard BP, Froger N, Hamon M, Gardier AM, Lanfumey L. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice. Journal of Neurochemistry. 95: 1713-23. PMID 16219031 DOI: 10.1111/j.1471-4159.2005.03488.x |
0.647 |
|
| 2005 |
Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature. 436: 103-7. PMID 16001069 DOI: 10.1038/Nature03694 |
0.692 |
|
| 2004 |
Bert L, Favale D, Jego G, Greve P, Guilloux JP, Guiard BP, Gardier AM, Suaud-Chagny MF, Lestage P. Rapid and precise method to locate microdialysis probe implantation in the rodent brain. Journal of Neuroscience Methods. 140: 53-7. PMID 15589334 DOI: 10.1016/j.jneumeth.2004.04.042 |
0.682 |
|
| 2004 |
David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C, Hunt SP, De Felipe C, Hamon M, Jacquot C, Gardier AM, Lanfumey L. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice. European Journal of Pharmacology. 492: 41-8. PMID 15145704 DOI: 10.1016/J.Ejphar.2004.03.016 |
0.683 |
|
| 2004 |
Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. Journal of Neurochemistry. 89: 54-63. PMID 15030389 DOI: 10.1046/j.1471-4159.2003.02304.x |
0.777 |
|
| Show low-probability matches. |
